Drugs that contain Saxagliptin Hydrochloride

1. List of Onglyza drug patents

ONGLYZA's oppositions filed in EPO
ONGLYZA Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE44186 ASTRAZENECA AB Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
Jul, 2023

(3 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7951400 ASTRAZENECA AB Coated tablet formulation and method
Nov, 2028

(5 years from now)

Market Authorisation Date: 31 July, 2009

Treatment: Method for treating type ii diabetes by administering saxagliptin; Method for treating type ii diabetes mellitus by administering saxagliptin alone or in combination with insulin, metformin, a thiazol...

Dosage: TABLET;ORAL

How can I launch a generic of ONGLYZA before it's patent expiration?
More Information on Dosage

ONGLYZA family patents

7

United States

3

Slovenia

3

Spain

3

European Union

2

Israel

2

Denmark

2

Hong Kong

2

Hungary

2

Argentina

2

Croatia

2

Portugal

2

Cyprus

2

Korea, Republic of

2

Poland

2

Taiwan, Province of China

2

RS

2

China

2

ME

1

South Africa

1

Mexico

1

Australia

1

Russia

1

Lithuania

1

Norway

1

Brazil

1

Malaysia

1

Peru

1

Georgia

1

Ukraine

1

Japan

1

Canada

1

New Zealand

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in